From: Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
Protein fold increase (95% CI)a
mRNA fold increase (95% CI)b
gag
1.5 (± 0.3)
1.5 (± 0.2)
pol
1.0 (± 0.1)
2.2 (± 0.2)
nef
1.7 (± 0.1)
1.6 (± 0.1)